The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics

Trial Profile

The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2016

At a glance

  • Drugs Montelukast (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Apr 2016 Time frame for primary endpoint (Asthma Control Test (ACT) Scores) changed from 0, 4, 8, 12, 16, 20, 24 weeks to 24 weeks as reported by ClinicalTrials.gov.
    • 15 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top